Nutritional factors, cognitive decline, and dementia
Tài liệu tham khảo
American Psychiatric Association Committee on Nomenclature and Statistics, Diagnostic and Statistical Manual of Mental Disorders, Washington, D.C., 1994.
Ames, 1993, Oxidants, antioxidants, and the degenerative diseases of aging, Proc. Natl. Acad. Sci. U.S.A., 90, 7915, 10.1073/pnas.90.17.7915
Amorim Cruz, 1996, Longitudinal changes in the intake of vitamins and minerals of elderly Europeans. SENECA Investigators, Eur. J. Clin. Nutr., 50, S77
Azzi, 1992, The protein kinase C family, Eur. J. Biochem., 208, 547, 10.1111/j.1432-1033.1992.tb17219.x
Barberger-Gateau, 2002, Fish, meat, and risk of dementia: cohort study, BMJ, 325, 932, 10.1136/bmj.325.7370.932
Behl, 1997, Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease, Cell Tissue Res., 290, 471, 10.1007/s004410050955
Bell, 1992, Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people, Acta Psychiatr. Scand., 86, 386, 10.1111/j.1600-0447.1992.tb03285.x
Bender, 1992, Trends in prevalence and magnitude of vitamin and mineral supplement usage and correlation with health status, J. Am. Diet. Assoc., 92, 1096, 10.1016/S0002-8223(21)00771-9
Benton, 1997, Thiamine supplementation mood and cognitive functioning, Psychopharmacology (Berl), 129, 66, 10.1007/s002130050163
Bertoni-Freddari, 1995, Vitamin E deficiency as a model of precocious brain aging: assessment by X-ray microanalysis and morphometry, Scanning Microsc., 9, 289
Birge, 1997, The role of estrogen in the treatment of Alzheimer's disease, Neurology, 48, S36, 10.1212/WNL.48.5_Suppl_7.36S
Birge, 1998, Hormones and the aging brain, Geriatrics, 53, S28
Birkhauser, 2000, Oestrogens and Alzheimer's disease, Int. J. Geriatr. Psychiatry, 15, 600, 10.1002/1099-1166(200007)15:7<600::AID-GPS155>3.0.CO;2-7
Bjorkegren, 2001, Serum cobalamin, folate, methylmalonic acid and total homocysteine as vitamin B12 and folate tissue deficiency markers amongst elderly Swedes—a population-based study, J. Intern. Med., 249, 423, 10.1046/j.1365-2796.2001.00819.x
Borroni, 2002, Homocysteine, vitamin B6, and vascular disease in patients with AD, Neurology, 59, 1475, 10.1212/WNL.59.9.1475
Bottiglieri, 1996, Folate, vitamin B12, and neuropsychiatric disorders, Nutr. Rev., 54, 382, 10.1111/j.1753-4887.1996.tb03851.x
Braak, 1998, Evolution of neuronal changes in the course of Alzheimer's disease, J. Neural Transm., 127, 10.1007/978-3-7091-6467-9_11
Bronner, 1993, Nutrient bioavailability, with special reference to calcium, J. Nutr., 123, 797, 10.1093/jn/123.5.797
Budge, 2000, Plasma total homocysteine and cognitive performance in a volunteer elderly population, Ann. N.Y. Acad. Sci., 903, 407, 10.1111/j.1749-6632.2000.tb06392.x
Cao, 1997, Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships, Free Radic. Biol. Med., 22, 749, 10.1016/S0891-5849(96)00351-6
Cardoso, 2001, Functional mitochondria are required for amyloid beta-mediated neurotoxicity, FASEB J., 15, 1439, 10.1096/fj.00-0561fje
Cattin, 1997, Factors associated with cognitive impairment among older Italian inpatients. Gruppo Italiano di Farmacovigilanza nell’Anziano (G.I.F.A.), J. Am. Geriatr. Soc., 45, 1324, 10.1111/j.1532-5415.1997.tb02931.x
Chandra, 2001, Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects, Nutrition, 17, 709, 10.1016/S0899-9007(01)00610-4
Christen, 2000, Oxidative stress and Alzheimer disease, Am. J. Clin. Nutr., 71, 621S, 10.1093/ajcn/71.2.621s
Chui, 1992, Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers, Neurology, 42, 473, 10.1212/WNL.42.3.473
Clarke, 1998, Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease, Arch. Neurol., 55, 1449, 10.1001/archneur.55.11.1449
Commenges, 2000, Intake of flavonoids and risk of dementia, Eur. J. Epidemiol., 16, 357, 10.1023/A:1007614613771
Cutler, 2004, Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A., 101, 2070, 10.1073/pnas.0305799101
Del Parigi, 2004, Nutritional deficiency, cognitive decline, and dementia, 135
Delanty, 2000, Antioxidant therapy in neurologic disease, Arch. Neurol., 57, 1265, 10.1001/archneur.57.9.1265
Den Heijer, 2003, Homocysteine and brain atrophy on MRI of non-demented elderly, Brain, 126, 170, 10.1093/brain/awg006
Doty, 1991, Olfactory dysfunction in three neurodegenerative diseases, Geriatrics, 46, 47
Dufouil, 2003, Homocysteine, white matter hyperintensities, and cognition in healthy elderly people, Ann. Neural., 53, 214, 10.1002/ana.10440
Duthie, 2002, Homocysteine, B vitamin status, and cognitive function in the elderly, Am. J. Clin. Nutr., 75, 908, 10.1093/ajcn/75.5.908
Engelhart, 2002, Dietary intake of antioxidants and risk of Alzheimer disease, J. Am. Med. Assoc., 287, 3223, 10.1001/jama.287.24.3223
Engelhart, 2002, Diet and risk of dementia: does fat matter? The Rotterdam Study, Neurology, 59, 1915, 10.1212/01.WNL.0000038345.77753.46
Farber, 1988, Predicting intellectual level from the Mini-Mental State Examination, J. Am. Geriatr. Soc., 36, 509, 10.1111/j.1532-5415.1988.tb04020.x
Fassbender, 1999, Homocysteine in cerebral macroangiography and microangiopathy, Lancet, 353, 1586, 10.1016/S0140-6736(99)00309-8
Fekkes, 1998, Abnormal amino acid metabolism in patients with early stage Alzheimer dementia, J. Neural Transm., 105, 287, 10.1007/s007020050058
Femstrom, 1972, Brain serotonin content: physiological regulation by plasma neutral amino acids, Science, 178, 414, 10.1126/science.178.4059.414
Figueroa, 2001, Abetapp secretases are co-expressed with Abetapp in the pancreatic islets, J. Alzheimers Dis., 3, 393, 10.3233/JAD-2001-3405
Flicker, 1991, Mild cognitive impairment in the elderly: predictors of dementia, Neurology, 41, 1006, 10.1212/WNL.41.7.1006
Foley, 2002, Dietary intake of antioxidants and risk of Alzheimer disease: food for thought, J. Am. Med. Assoc., 287, 3261, 10.1001/jama.287.24.3261
Fraser, 1996, Variables associated with cognitive function in elderly California Seventh-day Adventists, Am. J. Epidemiol., 143, 1181, 10.1093/oxfordjournals.aje.a008705
Frisoni, 2000, Mild cognitive impairment in the population and physical health: data on 1,435 individuals aged 75 to 95, J. Gerontol. A Biol. Sci. Med. Sci., 55, M322, 10.1093/gerona/55.6.M322
Gale, 1996, Cognitive impairment and mortality in a cohort of elderly people, BMJ, 312, 608, 10.1136/bmj.312.7031.608
Gold, 2002, Clinicopathological validation study of four sets of clinical criteria for vascular dementia, Am. J. Psychiatry, 159, 82, 10.1176/appi.ajp.159.1.82
Goodwin, 1983, Association between nutritional status and cognitive functioning in a healthy elderly population, J. Am. Med. Assoc., 249, 2917, 10.1001/jama.249.21.2917
Grant, 1999, Dietary links to Alzheimer's disease: 1999 update, J. Alzheimers Dis., 1, 197, 10.3233/JAD-1999-14-501
Green, 1999, Folate deficiency beyond megaloblastic anemia: hyperhomocysteinemia and other manifestations of dysfunctional folate status, Semin. Hematol., 36, 47
Haan, 2004, Can dementia be prevented? Brain aging in a population-based context, Annu. Rev. Public Health, 25, 1, 10.1146/annurev.publhealth.25.101802.122951
Halder, 1998, Protective role of black tea against oxidative damage of human red blood cells, Biochem. Biophys. Res. Commun., 244, 903, 10.1006/bbrc.1998.8366
Haller, 1996, Changes in the vitamin status of elderly Europeans: plasma vitamins A, E, B-6, B-12, folic acid and carotenoids. SENECA Investigators, Eur. J. Clin. Nutr., 50, S32
Hogervorst, 2002, Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease, Arch. Neurol., 59, 787, 10.1001/archneur.59.5.787
Honda, 2004, Oxidative stress and redox-active iron in Alzheimer's disease, Ann. N.Y. Acad. Sci., 1012, 179, 10.1196/annals.1306.015
Jack, 1999, Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment, Neurology, 52, 1397, 10.1212/WNL.52.7.1397
Jacques, 1999, The effect of folic acid fortification on plasma folate and total homocysteine concentrations, N. Engl. J. Med., 340, 1449, 10.1056/NEJM199905133401901
Jama, 1996, Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study, Am. J. Epidemiol., 144, 275, 10.1093/oxfordjournals.aje.a008922
Joosten, 1993, Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people, Am. J. Clin. Nutr., 58, 468, 10.1093/ajcn/58.4.468
Joseph, 1999, Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation, J. Neurosci., 19, 8114, 10.1523/JNEUROSCI.19-18-08114.1999
Joseph, 1998, Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits, J. Neurosci., 18, 8047, 10.1523/JNEUROSCI.18-19-08047.1998
Kagan, 1996, Stroke, 111
Kalaria, 1988, The glucose transporter of the human brain and blood-brain barrier, Ann. Neural., 24, 757, 10.1002/ana.410240610
Kalmijn, 1997, Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men, Am. J. Epidemiol., 145, 33, 10.1093/oxfordjournals.aje.a009029
Kalmijn, 1999, Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study, Am. J. Epidemiol., 150, 283, 10.1093/oxfordjournals.aje.a010000
Kalmijn, 2004, Dietary intake of fatty acids and fish in relation to cognitive performance at middle age, Neurology, 62, 275, 10.1212/01.WNL.0000103860.75218.A5
Kaplan, 2000, Cognitive performance is associated with glucose regulation in healthy elderly persons and can be enhanced with glucose and dietary carbohydrates, Am. J. Clin. Nutr., 72, 825, 10.1093/ajcn/72.3.825
Killiany, 2000, Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease, Ann. Neurol., 47, 430, 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I
Kirk, 1999, Diet and lifestyle characteristics associated with dietary supplement use in women, Public Health Nutr., 2, 69, 10.1017/S1368980099000099
Knopman, 1998, Current pharmacotherapies for Alzheimer's disease, Geriatrics, 53, S31
Krischer, 1997, Protein-facilitated export of arachidonic acid from pig neutrophils, J Biol. Chem., 272, 10601, 10.1074/jbc.272.16.10601
Kruman, 2000, Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity, J. Neurosci., 20, 6920, 10.1523/JNEUROSCI.20-18-06920.2000
Kruman, 2002, Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease, J Neurosci., 22, 1752, 10.1523/JNEUROSCI.22-05-01752.2002
Laurin, 2002, Vitamin E and C supplements and risk of dementia, J. Am. Med. Assoc., 288, 2266, 10.1001/jama.288.18.2266
Lehmann, 1999, Identification of cognitive impairment in the elderly: homocysteine is an early marker, Dement. Geriatr. Cogn. Disord., 10, 12, 10.1159/000017092
Lethem, 1997, Antioxidants and dementia, Lancet, 349, 1189, 10.1016/S0140-6736(05)62409-9
Lindenbaum, 1988, Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis, N. Engl. J. Med., 318, 1720, 10.1056/NEJM198806303182604
Lipton, 1997, Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor, Proc. Natl. Acad. Sci. U.S.A., 94, 5923, 10.1073/pnas.94.11.5923
Lokk, 2003, News and views on folate and elderly persons, J Gerontol. A Biol. Sci. Med. Sci., 58, 354, 10.1093/gerona/58.4.M354
Lowik, 1989, Nutrition and aging: dietary intake of “apparently healthy” elderly (Dutch Nutrition Surveillance System), J. Am. Coll. Nutr., 8, 347, 10.1080/07315724.1989.10720310
Luchsinger, 2002, Caloric intake and the risk of Alzheimer disease, Arch. Neurol., 59, 1258, 10.1001/archneur.59.8.1258
Luchsinger, 2003, Antioxidant vitamin intake and risk of Alzheimer disease, Arch. Neurol., 60, 203, 10.1001/archneur.60.2.203
Malouf, 2003, Folic acid with or without vitamin B12 for cognition and dementia, Cochrane Database Syst. Rev., 10.1002/14651858.CD004514
Marcus, 1998, Refusal to eat in the elderly, Nutr. Rev., 56, 163, 10.1111/j.1753-4887.1998.tb06130.x
Mark, 1997, Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation, J Neurosci., 17, 1046, 10.1523/JNEUROSCI.17-03-01046.1997
Markesbery, 1999, Oxidative alterations in Alzheimer's disease, Brain Pathol., 9, 133, 10.1111/j.1750-3639.1999.tb00215.x
Martin, 1997, Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro, Arterioscler. Thromb. Vasc. Biol., 17, 429, 10.1161/01.ATV.17.3.429
Martin, 2000, Effect of fruits, vegetables, or vitamin E-rich diet on vitamins E and C distribution in peripheral and brain tissues: implications for brain function, J Gerontol. A Biol. Sci. Med Sci., 55, B144, 10.1093/gerona/55.3.B144
Martins, 2001, Amyloid beta protein precursor metabolism as a modulator of islet beta-cell function, J Alzheimers Dis., 3, 397, 10.3233/JAD-2001-3406
Masaki, 2000, Association of vitamin E and C supplement use with cognitive function and dementia in elderly men, Neurology, 54, 1265, 10.1212/WNL.54.6.1265
Mattson, 2003, Will caloric restriction and folate protect against AD and PD?, Neurology, 60, 690, 10.1212/01.WNL.0000042785.02850.11
McCaddon, 1998, Total serum homocysteine in senile dementia of Alzheimer type, Int. J. Geriatr. Psychiatry, 13, 235, 10.1002/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO;2-8
McCaddon, 2001, Homocysteine and cognitive decline in healthy elderly, Dement. Geriatr. Cogn. Disord., 12, 309, 10.1159/000051275
McCaddon, 2003, Alzheimer's disease and total plasma aminothiols, Biol. Psychiatry, 53, 254, 10.1016/S0006-3223(02)01451-8
McCaddon, 2002, Functional vitamin B(12) deficiency and Alzheimer disease, Neurology, 58, 1395, 10.1212/WNL.58.9.1395
McGeer, 1990, 18Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scans, Can. J. Neural. Sci., 17, 1, 10.1017/S0317167100029930
McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939
Mcllroy, 2002, Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland, Stroke, 33, 2351, 10.1161/01.STR.0000032550.90046.38
Meador, 1993, Evidence for a central cholinergic effect of high-dose thiamine, Ann. Neurol., 34, 724, 10.1002/ana.410340516
Mendelsohn, 1998, Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey, Am. J. Epidemiol., 148, 38, 10.1093/oxfordjournals.aje.a009556
Meydani, 1997, Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial, J. Am. Med. Assoc., 277, 1380, 10.1001/jama.277.17.1380
Micheau, 1985, Chronic administration of sulbutiamine improves long term memory formation in mice: possible cholinergic mediation, Pharmacol. Biochem. Behav., 23, 195, 10.1016/0091-3057(85)90555-6
Miller, 2002, Homocysteine, vitamin B6, and vascular disease in AD patients, Neurology, 58, 1471, 10.1212/WNL.58.10.1471
Miller, 2003, Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging, Am J. Clin. Nutr., 78, 441, 10.1093/ajcn/78.3.441
Miller, 2004, The role of cholesterol and statins in Alzheimer's disease, Ann. Pharmacother., 38, 91, 10.1345/aph.1D104
Mirzoeva, 1996, The effect of propolis and its components on eicosanoid production during the inflammatory response, Prostaglandins Leukot. Essent. Fatty Acids, 55, 441, 10.1016/S0952-3278(96)90129-5
Moreiras, 1996, Longitudinal changes in the intake of energy and macronutrients of elderly Europeans. SENECA Investigators, Eur. J. Clin. Nutr., 50, S67
Moriguchi, 1997, Anti-ageing effect of aged garlic extract in the inbred brain atrophy mouse model, Clin. Exp. Pharmacol. Physiol., 24, 235, 10.1111/j.1440-1681.1997.tb01813.x
Morris, 2001, Mild cognitive impairment represents early-stage Alzheimer disease, Arch. Neurol., 58, 397, 10.1001/archneur.58.3.397
Morris, 1998, Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease, Alzheimer Dis. Assoc. Disord., 12, 121, 10.1097/00002093-199809000-00001
Morris, 2003, Dietary fats and the risk of incident Alzheimer disease, Arch. Neurol., 60, 194, 10.1001/archneur.60.2.194
Morris, 2002, Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study, J. Am. Med. Assoc., 287, 3230, 10.1001/jama.287.24.3230
Morris, 2003, Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease, Arch. Neurol., 60, 940, 10.1001/archneur.60.7.940
Morris, 2002, Vitamin E and cognitive decline in older persons, Arch. Neural., 59, 1125, 10.1001/archneur.59.7.1125
Morris, 2001, Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey, Am. J. Clin. Nutr., 73, 927, 10.1093/ajcn/73.5.927
Munro, 1981, Nutrition and ageing, Br. Med. Bull., 37, 83, 10.1093/oxfordjournals.bmb.a071681
Naurath, 1995, Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations, Lancet, 346, 85, 10.1016/S0140-6736(95)92113-3
Neugroschl, 2002, Biological markers in Alzheimer disease, Am. J. Geriatr. Psychiatry, 10, 660, 10.1176/appi.ajgp.10.6.660
Newton, 1999, Clinical and functional assessment of adults, 895
Nilsson, 1996, Hyperhomocysteinaemia—a common finding in a psychogeriatric population, Eur. J. Clin. Invest., 26, 853, 10.1111/j.1365-2362.1996.tb02129.x
Nilsson, 1999, Plasma homocysteine is a sensitive marker for tissue deficiency of both cobalamines and folates in a psychogeriatric population, Dement. Geriatr. Cogn. Disord., 10, 476, 10.1159/000017193
Nishiyama, 1997, Beneficial effects of aged garlic extract on learning and memory impairment in the senescence-accelerated mouse, Exp. Gerontol., 32, 149, 10.1016/S0531-5565(96)00062-9
Ortega, 1997, Dietary intake and cognitive function in a group of elderly people, Am. J. Clin. Nutr., 66, 803, 10.1093/ajcn/66.4.803
Ortega, 2002, Cognitive function in elderly people is influenced by vitamin E status, J. Nutr., 132, 2065, 10.1093/jn/132.7.2065
Paleologos, 1998, Cohort study of vitamin C intake and cognitive impairment, Am. J. Epidemiol., 148, 45, 10.1093/oxfordjournals.aje.a009559
Panza, 2004, Macronutrients, age-related cognitive decline, and dementia, 107
Parnetti, 1997, Role of homocysteine in age-related vascular and non-vascular diseases, Aging (Milano), 9, 241
Perkins, 1999, Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey, Am. J. Epidemiol., 150, 37, 10.1093/oxfordjournals.aje.a009915
Perrig, 1997, The relation between antioxidants and memory performance in the old and very old, J. Am. Geriatr. Soc., 45, 718, 10.1111/j.1532-5415.1997.tb01476.x
Petersen, 2000, Aging, mild cognitive impairment, and Alzheimer's disease, Neurol. Clin., 18, 789, 10.1016/S0733-8619(05)70226-7
Petersen, 1999, Mild cognitive impairment: clinical characterization and outcome, Arch. Neurol., 56, 303, 10.1001/archneur.56.3.303
Pietrzik, 1997, Causes and consequences of hyperhomocyst(e)inemia, Int. J. Vitam. Nutr. Res., 67, 389
Pitchumoni, 1998, Current status of antioxidant therapy for Alzheimer's Disease, J. Am. Geriatr. Soc., 46, 1566, 10.1111/j.1532-5415.1998.tb01544.x
Position of the American Dietetic Association: nutrition, aging, and the continuum of care, J. Am. Diet. Assoc. 100 (2000) 580–595.
Pradignac, 1995, Relationships between macronutrient intake, handicaps, and cognitive impairments in free living elderly people, Aging (Milano), 7, 67
Pratico, 2000, Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease, Am. J. Med., 109, 577, 10.1016/S0002-9343(00)00547-7
Prins, 2002, Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study, Neurology, 59, 1375, 10.1212/01.WNL.0000032494.05619.93
Quinlivan, 2002, Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease, Lancet, 359, 227, 10.1016/S0140-6736(02)07439-1
Ramassamy, 1993, Ginkgo biloba extract EGb 761 or trolox C prevent the ascorbic acid/Fe2+ induced decrease in synaptosomal membrane fluidity, Free Radic. Res. Commun., 19, 341, 10.3109/10715769309056523
Rampersaud, 2003, Folate: a key to optimizing health and reducing disease risk in the elderly, J. Am. Coll. Nutr., 22, 1, 10.1080/07315724.2003.10719270
Ravaglia, 2002, Plasma amino acid concentrations in healthy and cognitively impaired oldest-old individuals: associations with anthropometric parameters of body composition and functional disability, Br. J. Nutr., 88, 563, 10.1079/BJN2002700
Ravaglia, 2003, Homocysteine and cognitive function in healthy elderly community dwellers in Italy, Am. J. Clin. Nutr., 77, 668, 10.1093/ajcn/77.3.668
Ravaglia, 2000, Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment, Mech. Ageing Dev., 121, 251, 10.1016/S0047-6374(00)00221-9
Ravaglia, 2000, Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects, J Nutr. Health Aging, 4, 218
Refsum, 1998, Homocysteine and cardiovascular disease, Annu. Rev. Med., 49, 31, 10.1146/annurev.med.49.1.31
Reiman, 2001, Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A., 98, 3334, 10.1073/pnas.061509598
Reiman, 1996, Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E, N. Engl. J. Med., 334, 752, 10.1056/NEJM199603213341202
Reiman, 2004, Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia, Proc. Natl. Acad. Sci. U.S.A., 101, 284, 10.1073/pnas.2635903100
Reiter, 1995, Oxidative processes and antioxidative defense mechanisms in the aging brain, FASEB J., 9, 526, 10.1096/fasebj.9.7.7737461
Riedel, 1998, Age and cognitive function, Curr. Opin. Clin. Nutr. Metab. Care, 1, 579, 10.1097/00075197-199811000-00017
Riggs, 1996, Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study, Am. J. Clin. Nutr., 63, 306, 10.1093/ajcn/63.3.306
Rinaldi, 2003, Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease, Neurobiol. Aging, 24, 915, 10.1016/S0197-4580(03)00031-9
Ritchie, 2001, Classification criteria for mild cognitive impairment: a population-based validation study, Neurology, 56, 37, 10.1212/WNL.56.1.37
Riviere, 1998, Low plasma vitamin C in Alzheimer patients despite an adequate diet, Int. J. Geriatr. Psychiatry, 13, 749, 10.1002/(SICI)1099-1166(1998110)13:11<749::AID-GPS860>3.0.CO;2-T
Rogers, 1999, Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms, Neuropsychopharmacology, 20, 322, 10.1016/S0893-133X(98)00091-8
Roman, 2002, Defining dementia: clinical criteria for the diagnosis of vascular dementia, Acta Neurol. Scand., 6, 10.1034/j.1600-0404.106.s178.2.x
Roman, 1999, Executive control function: a rational basis for the diagnosis of vascular dementia, Alzheimer Dis. Assoc. Disord., 13, S69, 10.1097/00002093-199912001-00012
Roman, 1993, Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology, 43, 250, 10.1212/WNL.43.2.250
Rosenberg, 1992, Nutritional factors in physical and cognitive functions of elderly people, Am. J. Clin. Nutr., 55, 1237S, 10.1093/ajcn/55.6.1237S
Ross, 1999, Characterization of risk factors for vascular dementia: the Honolulu-Asia Aging Study, Neurology, 53, 337, 10.1212/WNL.53.2.337
Sano, 1997, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, N. Engl. J. Med., 336, 1216, 10.1056/NEJM199704243361704
Schmidt, 1998, Plasma antioxidants and cognitive performance in middle-aged and older adults: results of the Austrian Stroke Prevention Study, J. Am. Geriatr. Soc., 46, 1407, 10.1111/j.1532-5415.1998.tb06008.x
Selhub, 2000, B vitamins, homocysteine, and neurocognitive function in the elderly, Am. J. Clin. Nutr., 71, 614S, 10.1093/ajcn/71.2.614s
Selhub, 1993, Vitamin status and intake as primary determinants of homocysteinemia in an elderly population, J. Am. Med. Assoc., 270, 2693, 10.1001/jama.270.22.2693
Selley, 2002, The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease, Neurobiol. Aging, 23, 383, 10.1016/S0197-4580(01)00327-X
Seshadri, 2002, Plasma homocysteine as a risk factor for dementia and Alzheimer's disease, N. Engl. J. Med., 346, 476, 10.1056/NEJMoa011613
Shea, 2002, Homocysteine, folate deprivation and Alzheimer neuropathology, J. Alzheimers Dis., 4, 261, 10.3233/JAD-2002-4401
Sheu, 1994, Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease, Ann. Neural, 35, 312, 10.1002/ana.410350311
Silverman, 2001, Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome, J. Am. Med. Assoc., 286, 2120, 10.1001/jama.286.17.2120
Sinclair, 1998, Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia, Int. J. Geriatr. Psychiatry, 13, 840, 10.1002/(SICI)1099-1166(1998120)13:12<840::AID-GPS877>3.0.CO;2-R
Smith, 1999, Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion, Br. J. Psychiatry, 174, 525, 10.1192/bjp.174.6.525
Snowdon, 2000, Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study, Am. J. Clin. Nutr., 71, 993, 10.1093/ajcn/71.4.993
Solfrizzi, 2003, The role of diet in cognitive decline, J Neural Transm., 110, 95, 10.1007/s00702-002-0766-8
Solfrizzi, 2004, Italian longitudinal study on aging working group. Vascular risk factors, incidence of MCI, and rates of progression to dementia, Neurology, 63, 1882, 10.1212/01.WNL.0000144281.38555.E3
Solfrizzi, 2004, Dietary fatty acids, cognitive decline, and dementia, 91
Solfrizzi, 1999, High monounsaturated fatty acids intake protects against age-related cognitive decline, Neurology, 52, 1563, 10.1212/WNL.52.8.1563
Sparks, 2000, Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations, Ann. N.Y. Acad. Sci., 903, 335, 10.1111/j.1749-6632.2000.tb06384.x
Stoll, 1996, Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse, Pharmacopsychiatry, 29, 144, 10.1055/s-2007-979561
Subramaniam, 1998, The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25–35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease, Neurochem. Res., 23, 1403, 10.1023/A:1020754807671
Swan, 1990, Heritability of cognitive performance in aging twins. The National Heart, Lung, and Blood Institute Twin Study, Arch. Neural., 47, 259, 10.1001/archneur.1990.00530030025010
Thal, 2002, Phases of A beta-deposition in the human brain and its relevance for the development of AD, Neurology, 58, 1791, 10.1212/WNL.58.12.1791
Tombaugh, 1992, The mini-mental state examination: a comprehensive review, J. Am. Geriatr. Soc., 40, 922, 10.1111/j.1532-5415.1992.tb01992.x
Tucker, 1990, Nutrition status and brain function in aging, Am. J. Clin. Nutr., 52, 93, 10.1093/ajcn/52.1.93
Ueland, 1989, Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy, J. Lab. Clin. Med., 114, 473
Uemura, 2001, Amyloid beta-peptide inhibits neuronal glucose uptake by preventing exocytosis, Exp. Neurol., 170, 270, 10.1006/exnr.2001.7719
van Oort, 2003, Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study, Am. J. Clin. Nutr., 77, 1318, 10.1093/ajcn/77.5.1318
Varadarajan, 2000, Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity, J. Struct. Biol., 130, 184, 10.1006/jsbi.2000.4274
Vatassery, 1998, Vitamin E and other endogenous antioxidants in the central nervous system, Geriatrics, 53, S25
Ventura, 2001, Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects, Metabolism, 50, 1466, 10.1053/meta.2001.28079
Wahlin, 1996, Effects of serum vitamin B12 and folate status on episodic memory performance in very old age: a population-based study, Psychol. Aging, 11, 487, 10.1037/0882-7974.11.3.487
Wald, 2001, Randomized trial of folic acid supplementation and serum homocysteine levels, Arch. Intern. Med., 161, 695, 10.1001/archinte.161.5.695
Wang, 2001, Vitamin B(12) and folate in relation to the development of Alzheimer's disease, Neurology, 56, 1188, 10.1212/WNL.56.9.1188
Wenk, 1989, An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers, Psychopharmacology (Berl), 99, 431, 10.1007/BF00589888
White, 1996, Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study, J. Am. Med. Assoc., 276, 955, 10.1001/jama.276.12.955
Whitehouse, 1997, Dementia drug development: use of information systems to harmonize global drug development, Psychopharmacol. Bull., 33, 129
Xie, 2002, Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor, J Neurosci., 22, RC221, 10.1523/JNEUROSCI.22-10-j0001.2002
Zandi, 2004, Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study, Arch. Neurol., 61, 82, 10.1001/archneur.61.1.82